Showing:
◈ Informa Pharma Intelligence×
Northern Ireland could face medicine shortages after Brexit grace period ends next year, report claims
27/09/2021
Leading pharmaceutical research firm finds some drug firms will withdraw up to 90 per cent of their products from Northern Ireland as protocol hits exports.
Informa Pharma Intelligence (IPI) has found that some drug firms may withdraw up to 90% of their products from Northern Ireland, once the Brexit grace period has passed.